Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Shilpa Medicare LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:530549NSE Symbol: SHILPAMEDP/E(TTM):51.68
ISIN Demat:INE790G01031Div & Yield %:0.17EPS(TTM):5.61
Book Value(Rs):137.4709721Market Cap ( Cr.):5670.89Face Value(Rs):1
    Change Company 
Date Headline
12-Dec-25 Shilpa Medicare receives initial authorization from Europe for Rotigotine Transdermal Patch
24-Nov-25 Shilpa Medicare receives eight USFDA observations for Jadcherla facility
22-Nov-25 Shilpa Medicare's Unit IV completes USFDA inspection
17-Nov-25 Shilpa Medicare launches NODUCA™ therapy in India
13-Nov-25 Shilpa Medicare consolidated net profit rises 145.65% in the September 2025 quarter
06-Nov-25 Shilpa Medicare to announce Quarterly Result
27-Oct-25 Shilpa Medicare to sell its 31% stake in Sravathi Advance Process Technologies
16-Oct-25 Shilpa Medicare Ltd - Intimation Under Regulation 30 Read With Regulation 30A And Schedule III Of SEBI (Listing Obligati..
10-Oct-25 Shilpa Medicare Ltd - Shilpa Medicare Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018..
09-Oct-25 Shilpa Medicare Ltd - Shilpa Medicare Limited - General Updates
<< < 1 2 3 4   > >>